|
OPC Energy Ltd.
Condensed Consolidated Interim
Financial Statements
As of September 30, 2025
(Unaudited)
|
| Page |
|
|
F-3
|
|
|
F-4
|
|
|
F-5
|
|
|
F-7
|
|
|
F-8
|
|
|
F-9
|
|
|
F-12
|
|
|
F-14
|
| (1) |
Independent auditors’ review report of November 18, 2025 on the Company’s Condensed Consolidated Financial
Information as of September 30, 2025 and for the nine- and three-month periods then ended.
|
| (2) |
Independent auditors’ special report of November 18, 2025 on the Company’s separate interim financial information as of September 30, 2025, in accordance with Regulation 38D to the Securities Regulations (Periodic and Immediate Reports),
1970 and for the nine- and three-month periods then ended.
|
|
September 30
|
September 30
|
December 31
|
||||||||||
|
2025
|
2024
|
2024
|
||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||
|
NIS million
|
NIS million
|
NIS million
|
||||||||||
|
Current assets
|
||||||||||||
|
Cash and cash equivalents
|
2,300
|
1,151
|
962
|
|||||||||
|
Trade receivables
|
420
|
360
|
293
|
|||||||||
|
Other receivables and debit balances
|
108
|
163
|
90
|
|||||||||
|
Total current assets
|
2,828
|
1,674
|
1,345
|
|||||||||
|
Non‑current assets
|
||||||||||||
|
Long-term restricted deposits and cash
|
54
|
57
|
60
|
|||||||||
|
Long-term receivables and debit balances
|
158
|
231
|
162
|
|||||||||
|
Investments in associates
|
5,368
|
2,463
|
5,320
|
|||||||||
|
Long-term derivative financial instruments
|
43
|
54
|
44
|
|||||||||
|
Property, plant & equipment
|
4,281
|
7,048
|
4,238
|
|||||||||
|
Right‑of‑use assets and deferred expenses
|
638
|
790
|
637
|
|||||||||
|
Intangible assets
|
265
|
1,138
|
261
|
|||||||||
|
Total non‑current assets
|
10,807
|
11,781
|
10,722
|
|||||||||
|
Total assets
|
13,635
|
13,455
|
12,067
|
|||||||||
|
September 30
|
September 30
|
December 31
|
||||||||||
|
2025
|
2024
|
2024
|
||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||
|
NIS million
|
NIS million
|
NIS million
|
||||||||||
|
Current liabilities
|
||||||||||||
|
Loans and credit from banking corporations and financial institutions (including current maturities)
|
114
|
148
|
82
|
|||||||||
|
Current maturities of debt from non‑controlling interests
|
-
|
22
|
14
|
|||||||||
|
Current maturities of debentures
|
218
|
212
|
212
|
|||||||||
|
Trade payables
|
314
|
314
|
213
|
|||||||||
|
Payables and credit balances
|
354
|
183
|
123
|
|||||||||
|
Total current liabilities
|
1,000
|
879
|
644
|
|||||||||
|
Non‑current liabilities
|
||||||||||||
|
Long-term loans from banking corporations and financial institutions
|
2,569
|
2,953
|
2,150
|
|||||||||
|
Long-term debt from non-controlling interests
|
443
|
455
|
500
|
|||||||||
|
Debentures
|
1,165
|
1,664
|
1,663
|
|||||||||
|
Long-term lease liabilities
|
23
|
199
|
31
|
|||||||||
|
Long-term derivative financial instruments
|
-
|
36
|
-
|
|||||||||
|
Other long‑term liabilities
|
11
|
565
|
115
|
|||||||||
|
Deferred tax liabilities
|
552
|
517
|
543
|
|||||||||
|
Total non-current liabilities
|
4,763
|
6,389
|
5,002
|
|||||||||
|
Total liabilities
|
5,763
|
7,268
|
5,646
|
|||||||||
|
Equity
|
||||||||||||
|
Share capital
|
3
|
3
|
3
|
|||||||||
|
Share premium
|
5,745
|
3,990
|
3,993
|
|||||||||
|
Capital reserves
|
48
|
574
|
532
|
|||||||||
|
Retained earnings
|
478
|
196
|
224
|
|||||||||
|
Total equity attributable to the Company’s shareholders
|
6,274
|
4,763
|
4,752
|
|||||||||
|
Non‑controlling interests
|
1,598
|
1,424
|
1,669
|
|||||||||
|
Total equity
|
7,872
|
6,187
|
6,421
|
|||||||||
|
Total liabilities and equity
|
13,635
|
13,455
|
12,067
|
|||||||||
|
Yair Caspi
|
Giora Almogy
|
Shai Abramovitz
|
||
|
Chairman of the Board of Directors
|
CEO
|
Chief Comptroller1
|
|
For the nine-month period ended September 30
|
For the three-month period ended September 30
|
For the
year ended December 31
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
|
Revenues from sales and provision of services
|
2,256
|
2,190
|
895
|
879
|
2,779
|
|||||||||||||||
|
Cost of sales and services (excluding depreciation and amortization)
|
(1,643
|
)
|
(1,493
|
)
|
(603
|
)
|
(582
|
)
|
(1,931
|
)
|
||||||||||
|
Depreciation and amortization
|
(180
|
)
|
(245
|
)
|
(59
|
)
|
(90
|
)
|
(317
|
)
|
||||||||||
|
Gross income
|
433
|
452
|
233
|
207
|
531
|
|||||||||||||||
|
Share in profits of associates
|
423
|
150
|
211
|
64
|
166
|
|||||||||||||||
|
Compensation for loss of income
|
-
|
44
|
-
|
18
|
44
|
|||||||||||||||
|
General and administrative expenses
|
(295
|
)
|
(191
|
)
|
(147
|
)
|
(72
|
)
|
(263
|
)
|
||||||||||
|
Business development expenses
|
(10
|
)
|
(33
|
)
|
(4
|
)
|
(11
|
)
|
(45
|
)
|
||||||||||
|
Gain on loss of control in the US Renewable Energy Segment
|
-
|
-
|
-
|
-
|
259
|
|||||||||||||||
|
Other revenues (expenses), net
|
19
|
(50
|
)
|
35
|
2
|
(56
|
)
|
|||||||||||||
|
Operating profit
|
570
|
372
|
328
|
208
|
636
|
|||||||||||||||
|
Finance expenses
|
(216
|
)
|
(272
|
)
|
(74
|
)
|
(99
|
)
|
(339
|
)
|
||||||||||
|
Finance income
|
53
|
72
|
30
|
48
|
87
|
|||||||||||||||
|
Loss from extinguishment of financial liabilities
|
-
|
(49
|
)
|
-
|
(49
|
)
|
(49
|
)
|
||||||||||||
|
Finance expenses, net
|
(163
|
)
|
(249
|
)
|
(44
|
)
|
(100
|
)
|
(301
|
)
|
||||||||||
|
Profit before taxes on income
|
407
|
123
|
284
|
108
|
335
|
|||||||||||||||
|
Expenses for income tax
|
(74
|
)
|
(49
|
)
|
(48
|
)
|
(22
|
)
|
(138
|
)
|
||||||||||
|
Profit for the period
|
333
|
74
|
236
|
86
|
197
|
|||||||||||||||
|
Attributable to:
|
||||||||||||||||||||
|
The Company’s shareholders
|
254
|
83
|
183
|
81
|
111
|
|||||||||||||||
|
Non‑controlling interests
|
79
|
(9
|
)
|
53
|
5
|
86
|
||||||||||||||
|
Profit for the period
|
333
|
74
|
236
|
86
|
197
|
|||||||||||||||
|
Earnings per share attributable to the Company’s owners
|
||||||||||||||||||||
|
Basic diluted earnings per share (in NIS)
|
0.95
|
0.36
|
0.64
|
0.33
|
0.46
|
|||||||||||||||
|
For the nine-month period ended
September 30 |
For the three-month period ended
September 30
|
For the
year ended December 31
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
|
Profit for the period
|
333
|
74
|
236
|
86
|
197
|
|||||||||||||||
|
Components of other comprehensive income (loss) which, after being recognized in comprehensive income were or will be carried to profit and loss
|
||||||||||||||||||||
|
Effective portion of the change in the fair value of cash flow hedges
|
(2
|
)
|
25
|
3
|
-
|
42
|
||||||||||||||
|
Net change in fair value of derivative financial instruments used to hedge cash flows transferred to profit and loss
|
(5
|
)
|
(14
|
)
|
(3
|
)
|
(6
|
)
|
(11
|
)
|
||||||||||
|
Group’s share in other comprehensive income (loss) of associates, net of tax
|
(84
|
)
|
(29
|
)
|
9
|
27
|
13
|
|||||||||||||
|
Foreign currency translation differences in respect of foreign operations
|
(*) (555
|
)
|
84
|
(*) (123
|
)
|
(75
|
)
|
(8
|
)
|
|||||||||||
|
Tax on other comprehensive income (loss) items
|
41
|
(3
|
)
|
12
|
4
|
(6
|
)
|
|||||||||||||
|
Other comprehensive income (loss) for the period, net of tax
|
(605
|
)
|
63
|
(102
|
)
|
(50
|
)
|
30
|
||||||||||||
|
Total comprehensive income (loss) for the period
|
(272
|
)
|
137
|
134
|
36
|
227
|
||||||||||||||
|
Attributable to:
|
||||||||||||||||||||
|
The Company’s shareholders
|
(202
|
)
|
131
|
102
|
36
|
121
|
||||||||||||||
|
Non‑controlling interests
|
(70
|
)
|
6
|
32
|
-
|
106
|
||||||||||||||
|
Comprehensive income (loss) for the period
|
(272
|
)
|
137
|
134
|
36
|
227
|
||||||||||||||
|
Attributable to the Company’s shareholders
|
||||||||||||||||||||||||||||||||||||
|
Share capital
|
Share premium
|
Capital reserves
|
Hedge fund
|
Foreign operations translation reserve
|
Retained earnings
|
Total
|
Non‑controlling interests
|
Total equity
|
||||||||||||||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||||||||||||||
|
(Unaudited)
|
||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
|
For the nine-month period
ended September 30, 2025
|
||||||||||||||||||||||||||||||||||||
|
Balance as of January 1, 2025
|
3
|
3,993
|
247
|
49
|
236
|
224
|
4,752
|
1,669
|
6,421
|
|||||||||||||||||||||||||||
|
Issuance of shares (less issuance expenses)
|
*-
|
1,721
|
-
|
-
|
-
|
-
|
1,721
|
-
|
1,721
|
|||||||||||||||||||||||||||
|
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
35
|
35
|
|||||||||||||||||||||||||||
|
Share-based payment
|
-
|
-
|
4
|
-
|
-
|
-
|
4
|
1
|
5
|
|||||||||||||||||||||||||||
|
Exercised and expired options and RSUs
|
*-
|
31
|
(31
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
|
Dividend paid to non‑controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(38
|
)
|
(38
|
)
|
|||||||||||||||||||||||||
|
Other
|
-
|
-
|
(1
|
)
|
-
|
-
|
-
|
(1
|
)
|
1
|
-
|
|||||||||||||||||||||||||
|
Other comprehensive loss for the period, net of tax
|
-
|
-
|
-
|
(60
|
)
|
(396
|
)
|
-
|
(456
|
)
|
(149
|
)
|
(605
|
)
|
||||||||||||||||||||||
|
Profit for the period
|
-
|
-
|
-
|
-
|
-
|
254
|
254
|
79
|
333
|
|||||||||||||||||||||||||||
|
Balance as of September 30, 2025
|
3
|
5,745
|
219
|
(11
|
)
|
(160
|
)
|
478
|
6,274
|
1,598
|
7,872
|
|||||||||||||||||||||||||
|
For the nine-month period
ended September 30, 2024
|
||||||||||||||||||||||||||||||||||||
|
Balance as of January 1, 2024
|
2
|
3,210
|
248
|
25
|
250
|
113
|
3,848
|
1,394
|
5,242
|
|||||||||||||||||||||||||||
|
Issuance of shares (less issuance expenses)
|
1
|
778
|
-
|
-
|
-
|
-
|
779
|
-
|
779
|
|||||||||||||||||||||||||||
|
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
34
|
34
|
|||||||||||||||||||||||||||
|
Share-based payment
|
-
|
-
|
5
|
-
|
-
|
-
|
5
|
1
|
6
|
|||||||||||||||||||||||||||
|
Exercised and expired options and RSUs
|
*-
|
2
|
(2
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
|
Other
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(11
|
)
|
(11
|
)
|
|||||||||||||||||||||||||
|
Other comprehensive income (loss) for the period, net of tax
|
-
|
-
|
-
|
(13
|
)
|
61
|
-
|
48
|
15
|
63
|
||||||||||||||||||||||||||
|
Profit (loss) for the period
|
-
|
-
|
-
|
-
|
-
|
83
|
83
|
(9
|
)
|
74
|
||||||||||||||||||||||||||
|
Balance as of September 30, 2024
|
3
|
3,990
|
251
|
12
|
311
|
196
|
4,763
|
1,424
|
6,187
|
|||||||||||||||||||||||||||
|
Attributable to the Company’s shareholders
|
||||||||||||||||||||||||||||||||||||
|
Share capital
|
Share premium
|
Capital reserves
|
Hedge fund
|
Foreign operations translation reserve
|
Retained earnings
|
Total
|
Non‑controlling interests
|
Total equity
|
||||||||||||||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||||||||||||||
|
(Unaudited)
|
||||||||||||||||||||||||||||||||||||
|
For the three-month period
ended September 30, 2025
|
||||||||||||||||||||||||||||||||||||
|
Balance as of July 1, 2025
|
3
|
4,842
|
225
|
(17
|
)
|
(73
|
)
|
295
|
5,275
|
1,594
|
6,869
|
|||||||||||||||||||||||||
|
Issuance of shares (less issuance expenses)
|
*-
|
895
|
-
|
-
|
-
|
-
|
895
|
-
|
895
|
|||||||||||||||||||||||||||
|
Share-based payment
|
-
|
-
|
2
|
-
|
-
|
-
|
2
|
1
|
3
|
|||||||||||||||||||||||||||
|
Exercised and expired options and RSUs
|
*-
|
8
|
(8
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
|
Dividend paid to non‑controlling interests
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(29
|
)
|
(29
|
)
|
|||||||||||||||||||||||||
|
Other comprehensive income (loss) for the period, net of tax
|
-
|
-
|
-
|
6
|
(87
|
)
|
-
|
(81
|
)
|
(21
|
)
|
(102
|
)
|
|||||||||||||||||||||||
|
Profit for the period
|
-
|
-
|
-
|
-
|
-
|
183
|
183
|
53
|
236
|
|||||||||||||||||||||||||||
|
Balance as of September 30, 2025
|
3
|
5,745
|
219
|
(11
|
)
|
(160
|
)
|
478
|
6,274
|
1,598
|
7,872
|
|||||||||||||||||||||||||
|
For the three-month period
ended September 30, 2024
|
||||||||||||||||||||||||||||||||||||
|
Balance as of July 1, 2024
|
2
|
3,211
|
251
|
(2
|
)
|
370
|
115
|
3,947
|
1,434
|
5,381
|
||||||||||||||||||||||||||
|
Issuance of shares (less issuance expenses)
|
1
|
778
|
-
|
-
|
-
|
-
|
779
|
-
|
779
|
|||||||||||||||||||||||||||
|
Share-based payment
|
-
|
-
|
1
|
-
|
-
|
-
|
1
|
1
|
2
|
|||||||||||||||||||||||||||
|
Exercised and expired options and RSUs
|
*-
|
1
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
|
Other
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(11
|
)
|
(11
|
)
|
|||||||||||||||||||||||||
|
Other comprehensive income (loss) for the period, net of tax
|
-
|
-
|
-
|
14
|
(59
|
)
|
-
|
(45
|
)
|
(5
|
)
|
(50
|
)
|
|||||||||||||||||||||||
|
Profit for the period
|
-
|
-
|
-
|
-
|
-
|
81
|
81
|
5
|
86
|
|||||||||||||||||||||||||||
|
Balance as of September 30, 2024
|
3
|
3,990
|
251
|
12
|
311
|
196
|
4,763
|
1,424
|
6,187
|
|||||||||||||||||||||||||||
|
Attributable to the Company’s shareholders
|
||||||||||||||||||||||||||||||||||||
|
Share capital
|
Share premium
|
Capital reserves
|
Hedge fund
|
Foreign operations translation reserve
|
Retained earnings
|
Total
|
Non‑controlling interests
|
Total equity
|
||||||||||||||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||||||||||||||
|
(Audited)
|
||||||||||||||||||||||||||||||||||||
|
For the year ended December 31, 2024
|
||||||||||||||||||||||||||||||||||||
|
Balance as of January 1, 2024
|
2
|
3,210
|
248
|
25
|
250
|
113
|
3,848
|
1,394
|
5,242
|
|||||||||||||||||||||||||||
|
Issuance of shares (less issuance expenses)
|
1
|
779
|
-
|
-
|
-
|
-
|
780
|
-
|
780
|
|||||||||||||||||||||||||||
|
Investments by holders of non-controlling interests in equity of subsidiary
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
175
|
175
|
|||||||||||||||||||||||||||
|
Share-based payment
|
-
|
-
|
7
|
-
|
-
|
-
|
7
|
1
|
8
|
|||||||||||||||||||||||||||
|
Exercised and expired options and RSUs
|
*-
|
4
|
(4
|
)
|
-
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||||||||
|
Other
|
-
|
-
|
(4
|
)
|
-
|
-
|
-
|
(4
|
)
|
(7
|
)
|
(11
|
)
|
|||||||||||||||||||||||
|
Other comprehensive income (loss) for the year, net of tax
|
-
|
-
|
-
|
24
|
(14
|
)
|
-
|
10
|
20
|
30
|
||||||||||||||||||||||||||
|
Profit for the year
|
-
|
-
|
-
|
-
|
-
|
111
|
111
|
86
|
197
|
|||||||||||||||||||||||||||
|
Balance as of December 31, 2024
|
3
|
3,993
|
247
|
49
|
236
|
224
|
4,752
|
1,669
|
6,421
|
|||||||||||||||||||||||||||
|
For the nine-month period ended September 30
|
For the three-month period ended September 30
|
For the
year ended December 31
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
|
Cash flows from operating activities
|
||||||||||||||||||||
|
Profit for the period
|
333
|
74
|
236
|
86
|
197
|
|||||||||||||||
|
Adjustments:
|
||||||||||||||||||||
|
Depreciation and amortization
|
193
|
257
|
64
|
95
|
333
|
|||||||||||||||
|
Diesel fuel consumption
|
20
|
9
|
4
|
1
|
12
|
|||||||||||||||
|
Finance expenses, net
|
163
|
249
|
44
|
100
|
301
|
|||||||||||||||
|
Expenses for income tax
|
74
|
49
|
48
|
22
|
138
|
|||||||||||||||
|
Share in profits of associates
|
(423
|
)
|
(150
|
)
|
(211
|
)
|
(64
|
)
|
(166
|
)
|
||||||||||
|
Other expenses (revenues), net
|
(19
|
)
|
50
|
(35
|
)
|
(2
|
)
|
56
|
||||||||||||
|
Gain on loss of control in the US Renewable Energy Segment
|
-
|
-
|
-
|
-
|
(259
|
)
|
||||||||||||||
|
Share-based payment transactions
|
125
|
24
|
86
|
14
|
35
|
|||||||||||||||
|
466
|
562
|
236
|
252
|
647
|
||||||||||||||||
|
Changes in trade and other receivables
|
(166
|
)
|
(176
|
)
|
(36
|
)
|
(75
|
)
|
(64
|
)
|
||||||||||
|
Changes in trade payables, service providers, payables and other long-term liabilities
|
161
|
158
|
38
|
62
|
14
|
|||||||||||||||
|
(5
|
)
|
(18
|
)
|
2
|
(13
|
)
|
(50
|
)
|
||||||||||||
|
Dividends received from associates
|
203
|
205
|
108
|
179
|
235
|
|||||||||||||||
|
Income taxes paid
|
(8
|
)
|
(4
|
)
|
(8
|
)
|
-
|
(67
|
)
|
|||||||||||
|
Net cash provided by operating activities
|
656
|
745
|
338
|
418
|
765
|
|||||||||||||||
|
Cash flows used in investing activities
|
||||||||||||||||||||
|
Interest received
|
38
|
23
|
22
|
11
|
35
|
|||||||||||||||
|
Investment in associates
|
(479
|
)
|
(37
|
)
|
(84
|
)
|
(9
|
)
|
(737
|
)
|
||||||||||
|
Purchase of property, plant, and equipment, intangible assets and deferred expenses
|
(235
|
)
|
(1,203
|
)
|
(97
|
)
|
(698
|
)
|
(1,260
|
)
|
||||||||||
|
Loss of control in the US Renewable Energies Segment
|
-
|
-
|
-
|
-
|
134
|
|||||||||||||||
|
Proceeds for repayment of partnership capital from associates
|
3
|
95
|
-
|
95
|
95
|
|||||||||||||||
|
Other
|
5
|
25
|
(6
|
)
|
18
|
21
|
||||||||||||||
|
Net cash used for investing activities
|
(668
|
)
|
(1,097
|
)
|
(165
|
)
|
(583
|
)
|
(1,712
|
)
|
||||||||||
|
For the nine-month period ended September 30
|
For the three-month period ended September 30
|
For the year ended December 31
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
||||||||||||||||
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
NIS million
|
||||||||||||||||
|
Cash flows provided by financing activities
|
||||||||||||||||||||
|
Proceeds of share issuance, less issuance expenses (1)
|
1,721
|
779
|
895
|
779
|
780
|
|||||||||||||||
|
Proceeds of debenture issuance, less issuance expenses
|
-
|
198
|
-
|
-
|
198
|
|||||||||||||||
|
Receipt of long-term loans from banking corporations and financial institutions, net (2)
|
494
|
1,649
|
194
|
1,614
|
1,951
|
|||||||||||||||
|
Receipt of long-term debt from non-controlling interests
|
11
|
60
|
-
|
36
|
104
|
|||||||||||||||
|
Investments by holders of non-controlling interests in equity of subsidiary
|
35
|
34
|
-
|
-
|
175
|
|||||||||||||||
|
Change in short-term loans from banking corporations, net
|
10
|
(195
|
)
|
12
|
10
|
(204
|
)
|
|||||||||||||
|
Tax equity partner’s investment in US-based renewable energy projects
|
-
|
152
|
-
|
-
|
152
|
|||||||||||||||
|
Interest paid
|
(150
|
)
|
(198
|
)
|
(60
|
)
|
(79
|
)
|
(228
|
)
|
||||||||||
|
Dividend paid to non‑controlling interests
|
(38
|
)
|
-
|
(29
|
)
|
-
|
-
|
|||||||||||||
|
Repayment of long-term loans from banking corporations and others (2)
|
(68
|
)
|
(1,743
|
)
|
(25
|
)
|
(1,617
|
)
|
(1,755
|
)
|
||||||||||
|
Repayment of long-term loans from non-controlling interests
|
(62
|
)
|
(68
|
)
|
(13
|
)
|
(59
|
)
|
(76
|
)
|
||||||||||
|
Repayment of debentures (3)
|
(515
|
)
|
(193
|
)
|
(409
|
)
|
(97
|
)
|
(193
|
)
|
||||||||||
|
Other
|
12
|
(8
|
)
|
(2
|
)
|
(1
|
)
|
(13
|
)
|
|||||||||||
|
Net cash provided by financing activities
|
1,450
|
467
|
563
|
586
|
891
|
|||||||||||||||
|
Net increase (decrease) in cash and cash equivalents
|
1,438
|
115
|
736
|
421
|
(56
|
)
|
||||||||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
962
|
1,007
|
1,586
|
722
|
1,007
|
|||||||||||||||
|
Effect of exchange rate fluctuations on cash and cash equivalent balances
|
(100
|
)
|
29
|
(22
|
)
|
8
|
11
|
|||||||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
2,300
|
1,151
|
2,300
|
1,151
|
962
|
|||||||||||||||
| (1) |
For further details, see Note 7D.
|
| (2) |
For further details regarding OPC Israel's entering into financing agreements with banking corporations in Israel during the reporting period and the third quarter
of 2025, see Note 7A and Note 14B1 to the Annual Financial Statements.
|
| (3) |
For details regarding the partial early redemption of Debentures (Series B) in the third quarter of 2025, see Note 7A5.
|
| A. |
Statement of compliance with International Financial Reporting Standards (hereinafter - “IFRS”)
|
| B. |
Functional and presentation currency
|
| C. |
Use of estimates and judgments
|
| D. |
Seasonality
|
|
For the nine-month period ended September 30, 2025
|
||||||||||||||||||||||||
|
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
|
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
|
Revenues from sales and provision of services
|
1,789
|
2,201
|
146
|
331
|
(2,211
|
)
|
2,256
|
|||||||||||||||||
|
EBITDA after proportionate consolidation1
|
522
|
847
|
80
|
(12
|
)
|
(934
|
)
|
503
|
||||||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||
|
Share in profits of associates
|
423
|
|||||||||||||||||||||||
|
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(165
|
)
|
||||||||||||||||||||||
|
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(17
|
)
|
||||||||||||||||||||||
|
Total EBITDA
|
744
|
|||||||||||||||||||||||
|
Depreciation and amortization
|
(193
|
)
|
||||||||||||||||||||||
|
Finance expenses, net
|
(163
|
)
|
||||||||||||||||||||||
|
Other revenues, net
|
19
|
|||||||||||||||||||||||
|
(337
|
)
|
|||||||||||||||||||||||
|
Profit before taxes on income
|
407
|
|||||||||||||||||||||||
|
Expenses for income tax
|
(74
|
)
|
||||||||||||||||||||||
|
Profit for the period
|
333
|
|||||||||||||||||||||||
|
For the nine-month period ended September 30, 2024
|
||||||||||||||||||||||||
|
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
|
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
|
Revenues from sales and provision of services
|
1,835
|
1,328
|
188
|
92
|
(1,253
|
)
|
2,190
|
|||||||||||||||||
|
EBITDA after proportionate consolidation
|
541
|
447
|
84
|
(18
|
)
|
(451
|
)
|
603
|
||||||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||
|
Share in profits of associates
|
150
|
|||||||||||||||||||||||
|
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(61
|
)
|
||||||||||||||||||||||
|
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(13
|
)
|
||||||||||||||||||||||
|
Total EBITDA
|
679
|
|||||||||||||||||||||||
|
Depreciation and amortization
|
(257
|
)
|
||||||||||||||||||||||
|
Finance expenses, net
|
(249
|
)
|
||||||||||||||||||||||
|
Other expenses, net
|
(50
|
)
|
||||||||||||||||||||||
|
(556
|
)
|
|||||||||||||||||||||||
|
Profit before taxes on income
|
123
|
|||||||||||||||||||||||
|
Expenses for income tax
|
(49
|
)
|
||||||||||||||||||||||
|
Profit for the period
|
74
|
|||||||||||||||||||||||
|
For the three-month period ended September 30, 2025
|
||||||||||||||||||||||||
|
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
|
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
|
Revenues from sales and provision of services
|
714
|
806
|
57
|
137
|
(819
|
)
|
895
|
|||||||||||||||||
|
EBITDA after proportionate consolidation
|
258
|
349
|
21
|
(5
|
)
|
(377
|
)
|
246
|
||||||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||
|
Share in profits of associates
|
211
|
|||||||||||||||||||||||
|
General and administrative expenses at the US headquarters (not attributed to segments)
|
(94
|
)
|
||||||||||||||||||||||
|
General and administrative expenses at the Company’s headquarters (not attributed to segments)
|
(6
|
)
|
||||||||||||||||||||||
|
Total EBITDA
|
357
|
|||||||||||||||||||||||
|
Depreciation and amortization
|
(64
|
)
|
||||||||||||||||||||||
|
Finance expenses, net
|
(44
|
)
|
||||||||||||||||||||||
|
Other revenues, net
|
35
|
|||||||||||||||||||||||
|
(73
|
)
|
|||||||||||||||||||||||
|
Profit before taxes on income
|
284
|
|||||||||||||||||||||||
|
Expenses for income tax
|
(48
|
)
|
||||||||||||||||||||||
|
Profit for the period
|
236
|
|||||||||||||||||||||||
|
For the three-month period ended September 30, 2024
|
||||||||||||||||||||||||
|
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
|
In NIS million
|
(Unaudited)
|
|||||||||||||||||||||||
|
Revenues from sales and provision of services
|
761
|
448
|
49
|
45
|
(424
|
)
|
879
|
|||||||||||||||||
|
EBITDA after proportionate consolidation
|
255
|
169
|
21
|
(4
|
)
|
(170
|
)
|
271
|
||||||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||
|
Share in profits of associates
|
64
|
|||||||||||||||||||||||
|
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(29
|
)
|
||||||||||||||||||||||
|
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(5
|
)
|
||||||||||||||||||||||
|
Total EBITDA
|
301
|
|||||||||||||||||||||||
|
Depreciation and amortization
|
(95
|
)
|
||||||||||||||||||||||
|
Finance expenses, net
|
(100
|
)
|
||||||||||||||||||||||
|
Other revenues, net
|
2
|
|||||||||||||||||||||||
|
(193
|
)
|
|||||||||||||||||||||||
|
Profit before taxes on income
|
108
|
|||||||||||||||||||||||
|
Expenses for income tax
|
(22
|
)
|
||||||||||||||||||||||
|
Profit for the period
|
86
|
|||||||||||||||||||||||
|
For the year ended December 31, 2024
|
||||||||||||||||||||||||
|
Israel
|
US Energy Transition Segment
|
US Renewable Energies
|
Other activities in the US
|
Adjustments to consolidated
|
Consolidated – total
|
|||||||||||||||||||
|
In NIS million
|
(Audited)
|
|||||||||||||||||||||||
|
Revenues from sales and provision of services
|
2,312
|
1,796
|
228
|
145
|
(1,702
|
)
|
2,779
|
|||||||||||||||||
|
EBITDA after proportionate consolidation
|
639
|
588
|
112
|
(22
|
)
|
(608
|
)
|
709
|
||||||||||||||||
|
Adjustments:
|
||||||||||||||||||||||||
|
Share in profits of associates
|
166
|
|||||||||||||||||||||||
|
General and administrative expenses at the US headquarters (not attributed to US segments)
|
(89
|
)
|
||||||||||||||||||||||
|
General and administrative expenses at the Company’s headquarters (not attributed to the operating segments)
|
(20
|
)
|
||||||||||||||||||||||
|
Total EBITDA
|
766
|
|||||||||||||||||||||||
|
Depreciation and amortization
|
(333
|
)
|
||||||||||||||||||||||
|
Finance expenses, net
|
(301
|
)
|
||||||||||||||||||||||
|
Gain on loss of control in the US Renewable Energy Segment
|
259
|
|||||||||||||||||||||||
|
Other expenses, net
|
(56
|
)
|
||||||||||||||||||||||
|
(431
|
)
|
|||||||||||||||||||||||
|
Profit before taxes on income
|
335
|
|||||||||||||||||||||||
|
Expenses for income tax
|
(138
|
)
|
||||||||||||||||||||||
|
Profit for the year
|
197
|
|||||||||||||||||||||||
|
For the nine-month period ended September 30
|
For the three-month period ended September 30
|
For the
year ended December 31
|
||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2024
|
||||||||||||||||
|
In NIS million
|
(Unaudited)
|
(Unaudited)
|
(Audited)
|
|||||||||||||||||
|
Revenues from sale of electricity in Israel:
|
||||||||||||||||||||
|
Revenues from the sale of energy to private customers
|
986
|
1,121
|
427
|
516
|
1,368
|
|||||||||||||||
|
Revenues from energy sales to the system operator and other suppliers
|
158
|
146
|
54
|
50
|
165
|
|||||||||||||||
|
Revenues for capacity services
|
110
|
127
|
40
|
39
|
171
|
|||||||||||||||
|
Revenues from the sale of energy to the system operator, at cogeneration tariff
|
56
|
42
|
7
|
17
|
83
|
|||||||||||||||
|
Revenues from sale of steam in Israel
|
44
|
44
|
13
|
14
|
57
|
|||||||||||||||
|
Other revenues in Israel
|
2
|
23
|
2
|
-
|
23
|
|||||||||||||||
|
Total revenues from sale of energy and others in Israel (excluding infrastructure services)
|
1,356
|
1,503
|
543
|
636
|
1,867
|
|||||||||||||||
|
Revenues from private customers for infrastructure services
|
433
|
332
|
171
|
125
|
445
|
|||||||||||||||
|
Total revenues in Israel
|
1,789
|
1,835
|
714
|
761
|
2,312
|
|||||||||||||||
|
Revenues from sale of electricity from renewable energy (*)
|
-
|
164
|
-
|
39
|
195
|
|||||||||||||||
|
Revenues from sale of retail electricity and others
|
467
|
191
|
181
|
79
|
272
|
|||||||||||||||
|
Total revenues in the US
|
467
|
355
|
181
|
118
|
467
|
|||||||||||||||
|
Total revenues
|
2,256
|
2,190
|
895
|
879
|
2,779
|
|||||||||||||||
| (*) |
For details regarding deconsolidation and transition to the equity method in the fourth quarter of 2024 with respect to the investment in CPV Renewable, see Note 23E to the Annual
Financial Statements.
|
| A. |
Agreements for the acquisition of the remaining interests in the Shore power plant
|
| B. |
Commencement of construction of the Basin Ranch Power Plant and material agreements
related to the project
|
| B. |
Commencement of construction of the Basin Ranch Power Plant and material agreements related to the project (cont.)
|
| 1. |
Equity financing and provision of collateral:
|
| 2. |
Construction and equipment agreements:
|
| 2 |
The amount includes recognition of pre-financial closing development investments totaling approx. NIS 221 million (approx. USD 67 million). In addition, the CPV Group was credited with development fees totaling approx. NIS 93 million
(approx. USD 28 million) as part of the commitment to provide capital.
|
| B. |
Commencement of construction
of the Basin Ranch Power Plant and material agreements related to the project (cont.)
|
| 3. |
TEF Loan Agreement (senior debt)
|
|
Loan provision date
|
As from October 2025, in a number of tranches in accordance with the percentage of completion of the project’s construction.
|
|
|
The loan amount to the Project Company (100%)
|
Approx. USD 1.1 billion (approx. NIS 3.6 billion).
|
|
|
Interest rate
|
Annual interest at a fixed rate of 3%.
|
|
|
Amortization schedule of the principal and interest
|
Final repayment date: September 30, 2045.
The loan principal will be repaid in quarterly principal payments as from March 31, 2031, at a rate equal to 0.25% per
quarter, through March 31, 2032. Thereafter, repayments of principal and interest in accordance with an amortization schedule in a mortgage format (hereinafter - "Spitzer”).
Interest payments will be paid every quarter, including during the construction period.
|
|
|
Pledges
|
A first degree, senior, fixed and secured pledge on the project, its assets and the rights arising therefrom.
|
|
|
Default financial covenants
|
•
|
A historical 12-month debt service coverage ratio (DSCR) of 1.10x, which shall be measured on a quarterly basis starting one year after the commercial operation date (COD), as defined in the loan agreement. |
| • | Expected 5-year contracted DSCR of 1.20x on COD; the contracts for compliance with this ratio should be renewed or replaced two years before their termination, on a rolling basis. The project entered into hedging arrangements3 for a substantial portion of the project's capacity, which comply with this requirement. | |
| • | Performance-based project covenants for the past 12 months, which will be measured monthly as from the date on which full 12 calendar months will elapse after COD. The covenants set minimum uptime of 85% and maximum downtime of 15%, which may be remediated by presenting a remedial action plan and a reserve to finance the plan for the next 12 months. | |
|
Other key conditions (including certain collateral)
|
• | Distributions are subject to generally accepted definitions and conditions and to the following: (a) Compliance with contracted DSCR of 1.20x over 4 consecutive quarters, or a DSCR of 1.35x based on the total cash flow; and (b) a performance test (downtime/uptime) for the past 12 months, which includes certain conditions, which allow distribution even if the criteria are not met. |
| • |
Additional undertakings of the project interest holders (100%) totaling approx. NIS 631 million (approx.
USD 191 million) (the CPV Group’s share, as of the report approval date is approx. NIS 446 million (approx. USD 135 million)). These undertakings include collateral in the form of letters of credit (LCs) or other generally acceptable
collateral (such as cash) to secure certain matters pertaining to key agreements and the cost of the project, and to secure completion of construction (which can be forfeited after exhausting a budget contingency); and to secure the
project’s connection to the grid within 4 years, subject to an extension option (with the collateral released in accordance with the abovementioned date).
For further details regarding the balance of the guarantees provided by the Group in favor of the project as of
the report date and the report approval date, see Note 7A3.
|
|
| • | Additional project-level undertakings pertaining to collateral include, among other things, cash reserves or letters of credit on COD to secure expected DSR and operating expenses. | |
| • | Other undertakings and default and repayment events include, among other things, events that are deemed “change of control” including circumstances where CPV Power Holdings, LP (a wholly owned subsidiary partnership of the CPV Group) no longer holds and controls at least 50% of the Borrower, and circumstances where the CPV Group no longer holds or controls at least 50% of CPV Power Holdings, LP (as applicable in accordance with the relevant provisions), and generally accepted immediate repayment grounds such as non-payment, failure to comply with certain undertakings, breach of representations, undertakings and covenants, default events, regulatory and legal proceedings – all in accordance with the conditions and the remediation periods (as applicable) set in the loan agreement. | |
| B. |
Commencement of construction
of the Basin Ranch Power Plant and material agreements related to the project (cont.)
|
| 4. |
Agreement to acquire the remaining ownership rights in the project
|
| • |
At the Financial Closing Date of the TEF Loan (October 28, 2025), a total of approx. NIS 195 million (approx. USD 59 million) was paid for the seller's
investments prior to the financial closing, plus an estimate of additional investments made by the seller until the completion date of the Acquisition Transaction;6
|
| • |
At the completion date of the Acquisition Agreement, a total of approx. NIS 558 million (approx. USD 169 million) will be provided by way of cash and/or letters
of credit (LCs) in respect of the equity required in connection with the TEF Loan. Moreover, additional collateral will be provided by way of letters of credit (LCs) required to secure shareholders' liabilities related to the project in
the amount of approx. NIS 208 million (approx. USD 63 million7). It is noted that the said letters of credit shall be provided out of the Company's facilities and/or facilities guaranteed by the Company. For details regarding
increasing guarantee facilities subsequent to the report date, see Note 7A3 below.
|
| • |
During the Project’s construction period, from 2025 to 2029 - the seller will be paid an additional consideration amount of approx. NIS 265 million (approx.
USD 80 million), in four equal annual installments.
|
| 4 |
It is noted that if the transaction is not completed by this date, the agreement will be terminated in accordance with the termination arrangements set in the
Acquisition Agreement.
|
| 5 |
Under the Acquisition Agreement, the CPV Group serves as the guarantor for future payments payable to the seller subsequent to the completion of the
transaction. Furthermore, the seller is entitled to their share in the balance of future development fees in respect of the Project totaling approx. NIS 59 million (approx. USD 18 million), which are expected to be paid on the
Project’s commercial operation date.
|
| 6 |
At the Transaction Completion Date, if any, a calculation will be made regarding differences, if any, between the said estimate and the actual investments.
|
| 7 |
Of which a total of approx. US 6 million was provided as of the report approval date.
|
| A. |
Significant events during and subsequent to the Reporting Period
|
| 1. |
Banking financing agreements in OPC Israel
|
| 2. |
Financing agreement with Bank Leumi in the CPV Group
|
| A. |
Significant events during and subsequent to the Reporting Period (cont.)
|
| 2. |
Financing agreement with Bank Leumi in the CPV Group (cont.)
|
|
Borrower
|
CPV Group
|
|
|
Loan amount (principal)
|
USD 300 million (approx. NIS 1 billion).
|
|
|
Loan withdrawal dates
|
First payment of approx. NIS 460 million (USD 150 million) on the signing date, and a second payment of approx. NIS 460 million (USD 150 million) - no later than December 31, 2026,
concurrently with the expiry of the letter of credit (LC) issued on the signing date.
|
|
|
Interest rate (annual)
|
Long-term loan: Interest based on SOFR plus a 2.8% to 3.4% spread.
Financial guarantee fee (through the abovementioned letter of credit): 1.3% to 2%.
|
|
|
Repayment dates principal and interest
|
The interest on the loan principal shall be payable each quarter starting on March 31, 2027, with the interest accrued until
the first payment date is added to the loan principal;
The loan principal (including said accrued interest) is payable by March 31, 2027 in accordance with the amortization
schedule, as follows:
2027-2029: 5% per annum
2030-2031: 25% per annum
2032: %35.
Notwithstanding the foregoing, if the commercial operation of the Project commences during 2029, an adjustment will be made to
the principal payment rates (an increase from 1.25% per quarter to 6.25% per quarter) as of the first quarter after the commercial operation date, all such that the entire loan is repaid no later than December 31, 2032.
|
|
|
Default financial covenants
|
Financial covenants applicable to Borrower:
|
|
| • |
Total equity attributable to the shareholders of the CPV Group: More than USD 750 million;
|
|
| • |
Adjusted net debt to adjusted EBITDA ratio of the CPV Group is less than 7.0.
|
|
|
The financial covenants will be examined each quarter and will be subject to the terms and provisions (as well as to
agreed-upon remediation periods) and testing mechanisms as shall be set forth in the Financing Agreement.
As of the report date, the calculation of compliance with the covenants is as follows: (1) Equity - USD 1.6 billion;
(2) Adjusted net debt to adjusted EBITDA ratio - 3.4x.
|
||
|
Collateral
|
Subject to the relevant statutory provisions and the terms of the project’s financing agreements (including the TEF Loan
described in Note 6B), the Lender will be entitled to a lien on the account to which the dividends from the project companies are paid directly to the Borrower, all as stipulated in the Financing Agreement;
Furthermore, the Borrower undertook to have in place a negative pledge, except under the following circumstances:
(a) Existing and future limited resource project financing or the provision of liens under the financing of the portfolio assets of the Borrower and/or its subsidiaries and/or associates; (b) other existing and future permitted liens,
in the ordinary course of business, all as stipulated under the Financing Agreement.
|
|
| A. |
Significant events during and subsequent to the reporting period (cont.)
|
| 2. |
Financing Agreement with Bank Leumi in the CPV Group (cont.)
|
|
Additional material terms and conditions
|
Additional terms, undertakings and grounds for repayment (if applicable), include (as the case may be) certain restrictions on the Borrower and/or its subsidiaries and/or associates, with
respect to:
(a) Undertaking debt as stipulated in the Financing Agreement, except for the undertaking of a permitted debt (as defined in the Financing Agreement and under pre-determined conditions as
to the Borrower’s level of leveraging and liquidity) with respect to the areas of activity of the Borrower and/or its subsidiaries and/or associates (such as undertaking non-recourse project financing for a new project and/or the
refinancing a debt of an existing project or the financing of a portfolio of existing/ new projects through non-recourse financing, the Borrower’s undertaking corporate debts under the conditions stipulated in the Financing Agreement,
undertaking and/or extending certain credit facilities, etc.);
(b) Restrictions on the sale of assets, except for assets, which meet the pre-determined conditions set in the financing agreement as to the Borrower’s level of leveraging and liquidity
or assets, or assets which are immaterial to the business activities of the Borrower and/or its subsidiaries and/or associates;
(c) Restrictions on investments outside the normal business activities originating from the Borrower’s free cash flow, where (i) the net debt to EBITDA ratio covenant (as detailed above)
exceeds the value stipulated in the Financing Agreement; or (ii) the occurrence of certain default events in the project and/or other ongoing default events in the project, which were not remediated within the remediation periods
stipulated in the Financing Agreement;
(d) Other undertakings, default events and grounds for repayment as is generally accepted in agreements of this
type, including: Restrictions on change of control in the Borrower (including the Company and its controlling shareholders); restrictions on changes to the Borrower’s area of activity; cross acceleration as defined in the Financing
Agreement; non-payment; default events; legal or regulatory proceedings/matters as defined in the Financing Agreement; breach of covenants and undertakings (subject to remediation periods); cross-default for certain events pertaining to
the project (including material adverse effect events as defined in the Financing Agreement, breach of an undertaking to repay a TEF Loan or its acceleration, bankruptcy and abandonment event); non-payment of a debt of the Borrower or
the project above a certain threshold, all in accordance with the definitions, remediation periods and other conditions set in the Financing Agreement.
|
|
|
Payments
to the Borrower’s shareholders |
As from March 31, 2027, dividend distributions and repayment of shareholder loans8 are subject to the following financial covenants (as defined above):
|
|
| • |
Total equity attributable to the shareholders of the CPV Group: More than USD 1 billion;
|
|
| • |
Adjusted net debt to adjusted EBITDA ratio of the CPV Group is less than 4.0 up to 12 months subsequent to the
project's commercial operation date (COD) and less than 5.0 thereafter.
|
|
| Furthermore, under certain adverse circumstances defined in the Financing Agreement, such payments and additional payments to shareholders (such as management fees) will not be permitted even if the abovementioned financial covenants are met. | ||
|
Fees
|
Provisions have been set regarding fees, including upfront-fees and non-utilization fees, as is generally accepted
in financing agreements, as well as early repayment fees. It is clarified that the loan’s early repayment fees (except with respect to financial damage, if incurred) were set at declining levels over the loan term, such that after a set
number of years no early repayment fees will apply.
|
|
| A. |
Significant events during and subsequent to the reporting period (cont.)
|
| 3. |
Short-term credit facilities:
|
|
Facility amount
|
Utilization as of the report date (2)
|
Utilization immediately prior to the report approval date (1) (2)
|
||||||||||
|
Company
|
300
|
-
|
-
|
|||||||||
|
OPC Israel
|
300
|
2
|
2
|
|||||||||
|
The Company for the CPV Group (3)
|
Approx. 314 (USD 95 million)(4)
|
72
|
210
|
|||||||||
|
CPV Group(3)
|
Approx. 380 (USD 115 million) (4)
|
100
|
365
|
|||||||||
|
Total
|
1,294
|
174
|
577
|
|||||||||
| (1) |
As of November 14, 2025. The increase in utilization of letters of credit and bank guarantees immediately prior to the report approval date arises mainly from the provision of bank guarantees with respect to the financial closing of the
TEF Loan as detailed in Note 6B.
|
| (2) |
Mostly for the purpose of letters of credit and bank guarantees.
|
| (3) |
The facilities provided to the CPV Group or for the CPV Group, which are detailed in the above table, are backed with a Company guarantee.
|
| (4) |
It is noted that, subsequent to the report date, the Company's facility for the CPV Group increased to approx. NIS 545 million (approx. USD 165 million) and that of
the CPV Group increased to approx. NIS 562 million (approx. USD 170 million), mainly for financing part of the transaction to acquire the interests of the remaining partner in the Basin Ranch project, as detailed in Note 6B4 above.
|
| 4. |
In May 2025, Midroog assigned an initial rating of A1.il with a stable outlook for the Company and its
debentures. In addition, in May 2025, Ma’alot S&P upgraded the Company's credit rating to ilA with a stable outlook and the rating of its debentures to ilA+, following an improvement in business profile and financial ratios.
|
| 5. |
On September 30, 2025, the Company repaid, by way of partial early redemption, approx. NIS 256 million par value
in Debentures (Series B) in addition to the fixed payment in accordance with the amortization schedule of Debentures (Series B) as of that date. The total amount redeemed with respect to the partial early redemption, including linkage,
is approx. NIS 302 million.
|
| B. |
Changes in the Group’s material guarantees:
|
|
As of September 30, 2025
|
As of December 31, 2024
|
|||||||
|
NIS million
|
NIS million
|
|||||||
|
In respect of operating projects in Israel (Rotem, Hadera, Zomet and Gat) (1)
|
164
|
249
|
||||||
|
For projects under construction and development in Israel (Sorek 2 and consumers’ premises)
|
73
|
74
|
||||||
|
In respect of the filing of a bid in the Sorek tender (2)
|
50
|
100
|
||||||
|
In respect of virtual supply activity in Israel (3)
|
88
|
21
|
||||||
|
In respect of projects under construction and development in the US (CPV Group)*
|
265
|
339
|
||||||
|
For the Basin Ranch Project* (4)
|
41
|
-
|
||||||
|
In respect of operating projects in the US Renewable Energies and Other Segment*
|
37
|
22
|
||||||
|
Total
|
718
|
805
|
||||||
| (1) |
The decrease arises mainly from the release of a bank guarantee provided by OPC Israel for Zomet in favor of ILA
totaling NIS 67 million (for further details, see Note 10B5 to the Annual Financial Statements).
|
| (2) |
The decrease arises from a decrease in bank guarantee provided by OPC Israel in connection with the Sorek tender, as described in Note 14C3 to the Annual Financial
Statements.
|
| (3) |
The increase stems from an increase of the bank guarantee provided in favor of the system operator in respect of the virtual supply activity due to seasonality.
|
| (4) |
Immediately prior to the report approval date, the balance of the guarantees stands at approx. NIS 559 million (approx. USD 169 million), which arises mainly from
the provision of bank guarantees with respect to the financial closing of the TEF Loan as described in Note 6B.
|
| C. |
Financial covenants:
|
|
Ratio
|
Required value – Series B
|
Required value – Series C and D
|
Actual value
|
|||
|
Net financial debt (1) to adjusted EBITDA (2)
|
Will not exceed 13 (for distribution purposes – 11)
|
Will not exceed 13 (for distribution purposes – 11)
|
3.3
|
|||
|
The Company shareholders’ equity (“separate”)
|
Will not fall below NIS 250 million (for distribution purposes – NIS 350 million)
|
With respect to Debentures (Series C): will not fall below NIS 1 billion (for distribution purposes – NIS 1.4 billion)
With respect to Debentures (Series D): will not fall below NIS 2 billion (for distribution purposes – NIS 2.4 billion)
|
Approx. NIS 6,274 million
|
|||
|
The Company’s equity to asset ratio (“separate”)
|
Will not fall below 17% (for distribution purposes: 27%)
|
Will not fall below 20% (for distribution
purposes: 30%)
|
82%
|
|||
|
The Company’s equity to asset ratio (“consolidated”)
|
--
|
Will not fall below 17%
|
58%
|
| C. |
Financial covenants: (cont.)
|
|
Financial covenants
|
Breach ratio
|
Actual value
|
||
|
Covenants applicable to OPC Israel with respect to the corporate financing agreements9
|
||||
|
OPC Israel’s equity capital
|
Will not fall below NIS 1,100 million
|
Approx. NIS 2,216 million
|
||
|
OPC Israel’s equity to asset ratio
|
Will not fall below 20%
|
38%
|
||
|
OPC Israel’s ratio of net debt to EBITDA
|
Will not exceed 8
|
3.8
|
||
|
Covenants applicable to Hadera in connection with the Hadera Financing Agreement
|
||||
|
Minimum expected DSCR
|
1.10
|
1.13
|
||
|
Average expected DSCR
|
1.10
|
1.67
|
||
|
LLCR
|
1.10
|
1.57
|
||
|
Covenants applicable to the Company in connection with binding credit facilities with Israeli banking corporations10
|
||||
|
The Company shareholders’ equity (“separate”)
|
Will not fall below NIS 1,200 million
|
Approx. NIS 6,274 million
|
||
|
The Company’s equity to asset ratio (“separate”)
|
Will not fall below 30%
|
82%
|
||
|
The Company’s net debt to EBITDA ratio
|
Will not exceed 12
|
3.3
|
||
| D. |
Capital raising
|
| 1. |
In June 2025, the Company issued to the public 21,303,200 ordinary shares of NIS 0.01 par value each, of which a total of 7,923,600 ordinary shares were issued to the Parent Company. The gross proceeds of the issuance totaled NIS 850
million and the issuance expenses totaled approx. NIS 23 million.
|
| 2. |
In August 2025, the Company issued to qualified investors 18,750,000 ordinary shares of NIS 0.01 par value each. The gross proceeds of the issuance totaled NIS 900 million and the issuance expenses totaled approx. NIS 6 million.
|
| E. |
Shelf prospectus
|
| F. |
Equity compensation plans
|
| 1. |
Allocations of offered securities in the Reporting Period and thereafter:
|
|
Offerees and
allotment date |
No. of options at the grant date (in thousands)
|
Average fair value of each option at the grant date (in NIS)
|
Exercise price per option
(in NIS, unlinked) |
Standard deviation (1)
|
Risk-free interest rate (2)
|
Cost of benefit
(in NIS million) (3)
|
|||||||||||||||
|
Executives, March 2025
|
441
|
11.80
|
31.98
|
30.4%-34.5
|
%
|
4.09%-4.15
|
%
|
Approx. 5.0
|
|||||||||||||
|
CEO, July 2025 (4)
|
646
|
19.84
|
43.39
|
31.2%-31.8
|
%
|
3.93%-3.94
|
%
|
Approx. 12.8
|
|||||||||||||
| (1) |
The standard deviation is calculated based on historical volatility of the Company’s share over the expected life of the option until exercise date.
|
| (2) |
The rate of the risk-free interest is based on the Fair Spread database and an expected life of 4 to 6 years.
|
| (3) |
This amount will be recorded in profit and loss over the vesting period of each tranche.
|
| (4) |
The fair value of the options in the above table was calculated immediately prior to the date of the general meeting’s approval – August 26, 2025.
|
| F. |
Equity compensation plans (cont.)
|
| 2. |
Exercise of options and issuance of shares:
|
| 3. |
Expiry of options during the Reporting Period
|
| G. |
Profit sharing compensation plan for CPV Group employees
|
| A. |
Commitments (Including with Related and Interested Parties)
|
| B. |
Claims and other liabilities
|
| A. |
Financial instruments measured at fair value for disclosure purposes only
|
|
As of September 30, 2025
|
||||||||
|
Carrying value (*)
|
Fair value
|
|||||||
|
In NIS million
|
(Unaudited)
|
(Unaudited)
|
||||||
|
Loans from banking corporations and financial institutions (Level 2)
|
2,686
|
2,700
|
||||||
|
Loans from non‑controlling interests (Level 2)
|
443
|
448
|
||||||
|
Debentures (Level 1)
|
1,385
|
1,353
|
||||||
|
4,514
|
4,501
|
|||||||
|
As of September 30, 2024
|
||||||||
|
Carrying value (*)
|
Fair value
|
|||||||
|
In NIS million
|
(Unaudited)
|
(Unaudited)
|
||||||
|
Loans from banking corporations and financial institutions (Level 2)
|
3,103
|
3,091
|
||||||
|
Loans from non‑controlling interests (Level 2)
|
478
|
488
|
||||||
|
Debentures (Level 1)
|
1,878
|
1,784
|
||||||
|
5,459
|
5,363
|
|||||||
|
As of December 31, 2024
|
||||||||
|
Carrying value (*)
|
Fair value
|
|||||||
|
In NIS million
|
(Audited)
|
(Audited)
|
||||||
|
Loans from banking corporations and financial institutions (Level 2)
|
2,234
|
2,237
|
||||||
|
Loans from non‑controlling interests (Level 2)
|
514
|
508
|
||||||
|
Debentures (Level 1)
|
1,891
|
1,805
|
||||||
|
4,639
|
4,550
|
|||||||
| B. |
Fair value hierarchy of financial instruments measured at fair value
|
|
As of September 30
|
As of December 31
|
|||||||||||
|
2025
|
2024
|
2024
|
||||||||||
|
In NIS million
|
(Unaudited)
|
(Audited)
|
||||||||||
|
Financial assets
|
||||||||||||
|
Derivatives used for hedge accounting
|
||||||||||||
|
CPI swap contracts (Level 2)
|
43
|
46
|
(*) 44
|
|
||||||||
|
Interest rate swaps (SOFR) (Level 2) (1)
|
-
|
14
|
-
|
|||||||||
|
Total
|
43
|
60
|
44
|
|||||||||
|
Financial liabilities
|
||||||||||||
|
Derivatives used for hedge accounting
|
||||||||||||
|
CPI swap contracts (Level 2)
|
-
|
(1
|
)
|
(*) (1
|
)
|
|||||||
|
Interest rate swaps (SOFR) (Level 2) (1)
|
-
|
(12
|
)
|
-
|
||||||||
|
Electricity price hedge contracts (the US renewable energy segment) (Level 3) (1)
|
-
|
(30
|
)
|
-
|
||||||||
|
Total
|
-
|
(43
|
)
|
(1
|
)
|
|||||||
| (1) |
The balances as of September 30, 2024 are in respect of CPV Renewable. For details regarding deconsolidation and transition to the equity method in the fourth quarter of 2024 with respect to the investment in CPV Renewable, see Note 23E
to the Annual Financial Statements.
|
| A. |
General
|
| 1. |
Further to Note 1 to the Annual Financial Statements, in June 2025, there was a further escalation of the geopolitical situation, with the outbreak of a large-scale military conflict between Israel and Iran (hereinafter – “Operation Rising Lion"), which included missile attacks by Iran, the closure of Israeli airspace, a general state of emergency in the Israeli home front and a substantial escalation in the regional arena.
On June 24, 2025, a ceasefire with Iran was declared, which is in place as of the report approval date. Furthermore, during October 2025, a ceasefire was declared in the Gaza front between the State of Israel and the terrorist organization
Hamas, which led to a significant decrease in the intensity of fighting and in the scope of attacks against Israel by the terrorist organizations in Yemen. However, the situation in Israel continues to be characterized by substantial
geopolitical uncertainty.
|
| 2. |
In the nine‑month periods ended September 30, 2025 and 2024 the Group purchased property, plant and equipment for a total of approx. NIS 206 million and approx. NIS 982 million, respectively. Furthermore, these amounts include non-cash
purchases totaling approx. NIS 17 million and approx. NIS 38 million during these periods, respectively.
|
| 3. |
For further details regarding agreements to acquire additional rights in associates in the Reporting Period and thereafter, and financial closing and commencement of construction of the Basin Ranch Project subsequent to the report date
and disclosure of material agreements in the project, see Note 6.
|
| 4. |
For further details regarding developments in credit from banking corporations and others, debentures, credit ratings of the Company and its debentures, guarantees and equity in the Reporting Period and thereafter, see Note 7.
|
| 5. |
For further details regarding developments in commitments (including with related parties and interested parties), claims and other commitments during the Reporting Period and thereafter, see Note 8.
|
| B. |
OPC Israel
|
| C. |
CPV Group
|
| 1. |
Further to Note 23E to the Annual Financial Statements regarding the investment agreement in the US Renewable Energy
Segment, a further total of approx. NIS 330 million (approx. USD 100 million) was invested in the reporting period by the Investor.
|
| 2. |
Further to Note 23A3 to the Annual Financial Statements, following is information regarding investment undertakings and provision of loans by OPC Power’s partners (in USD million):
|
|
Immediately prior to the report approval date
|
As of September 30, 2025
|
As of December 31, 2024
|
||||||||||
|
Total investment undertakings and loan provision (a)
|
1,535
|
1,535
|
1,535
|
|||||||||
|
Utilization (b)
|
(1,535
|
)
|
(1,510
|
)
|
(1,455
|
)
|
||||||
|
Balance of investment undertakings and loan provision
|
-
|
25
|
80
|
|||||||||
| A. |
Excluding an additional investment commitment for backing guarantees which were or will be provided for the purpose
of development and expansion of projects – each partner based on its pro rata share in the partnership, for a total of approx. NIS 248 million (approx. USD 75 million).
|
| B. |
In the Reporting Period, the Company and non-controlling interests (both directly and indirectly) made equity investments in the Partnership and advanced loans totaling approx. USD 42 million (approx. NIS 146 million) and approx. USD 13
million (approx. NIS 48 million), respectively. Subsequent to the report date, in October 2025, equity investments in the Partnership were made and additional loans were advanced totaling approx. USD 19 million (approx. NIS 63 million) and
approx. USD 6 million (approx. NIS 20 million), respectively.
|
| 3. |
Dividends and capital distributions from associates
|
| 11 |
Non-recourse project financing, as accepted in agreements of this type.
|
|
As of September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Cash and cash equivalents
|
D
|
199
|
1,067
|
1,266
|
||||||||||
|
Restricted cash
|
D
|
12,628
|
(1,067
|
)
|
11,561
|
|||||||||
|
Property, plant & equipment
|
A,C
|
779,191
|
58,134
|
837,325
|
||||||||||
|
Intangible assets
|
C
|
25,231
|
(25,231
|
)
|
-
|
|||||||||
|
Other assets
|
31,436
|
-
|
31,436
|
|||||||||||
|
Total assets
|
848,685
|
32,903
|
881,588
|
|||||||||||
|
Accounts payable and deferred expenses
|
A
|
12,432
|
(6,802
|
)
|
5,630
|
|||||||||
|
Other liabilities
|
F
|
495,174
|
(7,614
|
)
|
487,560
|
|||||||||
|
Total liabilities
|
507,606
|
(14,416
|
)
|
493,190
|
||||||||||
|
Partners’ equity
|
A
|
341,079
|
47,319
|
388,398
|
||||||||||
|
Total liabilities and equity
|
848,685
|
32,903
|
881,588
|
|||||||||||
|
As of September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Cash and cash equivalents
|
D
|
85
|
1,560
|
1,645
|
||||||||||
|
Restricted cash
|
D
|
19,612
|
(1,560
|
)
|
18,052
|
|||||||||
|
Property, plant & equipment
|
A,C
|
800,887
|
52,723
|
853,610
|
||||||||||
|
Intangible assets
|
C
|
26,101
|
(26,101
|
)
|
-
|
|||||||||
|
Other assets
|
25,860
|
-
|
25,860
|
|||||||||||
|
Total assets
|
872,545
|
26,622
|
899,167
|
|||||||||||
|
Accounts payable and deferred expenses
|
A
|
17,577
|
(10,905
|
)
|
6,672
|
|||||||||
|
Other liabilities
|
550,137
|
-
|
550,137
|
|||||||||||
|
Total liabilities
|
567,714
|
(10,905
|
)
|
556,809
|
||||||||||
|
Partners’ equity
|
A
|
304,831
|
37,527
|
342,358
|
||||||||||
|
Total liabilities and equity
|
872,545
|
26,622
|
899,167
|
|||||||||||
|
As of December 31, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Cash and cash equivalents
|
D
|
43
|
444
|
487
|
||||||||||
|
Restricted cash
|
D
|
4,793
|
(444
|
)
|
4,349
|
|||||||||
|
Property, plant & equipment
|
A, C
|
797,304
|
57,331
|
854,635
|
||||||||||
|
Intangible assets
|
C
|
25,883
|
(25,883
|
)
|
-
|
|||||||||
|
Other assets
|
36,526
|
-
|
36,526
|
|||||||||||
|
Total assets
|
864,549
|
31,448
|
895,997
|
|||||||||||
|
Accounts payable and deferred expenses
|
A
|
13,820
|
(6,360
|
)
|
7,460
|
|||||||||
|
Other liabilities
|
530,317
|
-
|
530,317
|
|||||||||||
|
Total liabilities
|
544,137
|
(6,360
|
)
|
537,777
|
||||||||||
|
Partners’ equity
|
A
|
320,412
|
37,808
|
358,220
|
||||||||||
|
Total liabilities and equity
|
864,549
|
31,448
|
895,997
|
|||||||||||
|
For the nine-month period ended September 30, 2025
|
||||||||||||||||||
|
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||
|
Revenues
|
B
|
305,412
|
(267
|
)
|
1,214
|
306,359
|
||||||||||||
|
Operating expenses
|
A
|
142,979
|
(7,194
|
)
|
1,214
|
136,999
|
||||||||||||
|
Depreciation and amortization
|
A
|
20,838
|
5,296
|
-
|
26,134
|
|||||||||||||
|
Operating profit
|
141,595
|
1,631
|
-
|
143,226
|
||||||||||||||
|
Finance expenses
|
B,F
|
28,376
|
(9,101
|
)
|
-
|
19,275
|
||||||||||||
|
Profit for the period
|
113,219
|
10,732
|
-
|
123,951
|
||||||||||||||
|
Other comprehensive loss
|
B
|
(20,052
|
)
|
(1,220
|
)
|
-
|
(21,272
|
)
|
||||||||||
|
Comprehensive income for the period
|
93,167
|
9,512
|
-
|
102,679
|
||||||||||||||
|
For the nine-month period ended September 30, 2024
|
||||||||||||||||||||
|
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||||
|
Revenues
|
B |
212,728
|
(1,384
|
)
|
17,247
|
228,591
|
||||||||||||||
|
Operating expenses
|
A |
93,943
|
(6,602
|
)
|
17,247
|
104,588
|
||||||||||||||
|
Depreciation and amortization
|
A |
20,591
|
5,296
|
-
|
25,887
|
|||||||||||||||
|
Operating profit
|
98,194
|
(78
|
)
|
-
|
98,116
|
|||||||||||||||
|
Finance expenses
|
B |
16,732
|
(4,325
|
)
|
-
|
12,407
|
||||||||||||||
|
Profit for the period
|
81,462
|
4,247
|
-
|
85,709
|
||||||||||||||||
|
Other comprehensive income (loss)
|
B |
2,442
|
(2,778
|
)
|
-
|
(336
|
)
|
|||||||||||||
|
Comprehensive income for the period
|
83,904
|
1,469
|
-
|
85,373
|
||||||||||||||||
|
For the three-month period ended September 30, 2025
|
||||||||||||||||||
|
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||
|
Revenues
|
B |
105,597
|
878
|
5,265
|
111,740
|
|||||||||||||
|
Operating expenses
|
A |
39,399
|
(2,482
|
)
|
5,265
|
42,182
|
||||||||||||
|
Depreciation and amortization
|
A |
6,944
|
1,765
|
-
|
8,709
|
|||||||||||||
|
Operating profit
|
59,254
|
1,595
|
-
|
60,849
|
||||||||||||||
|
Finance expenses
|
B, F |
9,290
|
464
|
-
|
9,754
|
|||||||||||||
|
Profit for the period
|
49,964
|
1,131
|
-
|
51,095
|
||||||||||||||
|
Other comprehensive loss
|
B |
(410
|
)
|
(878
|
)
|
-
|
(1,288
|
)
|
||||||||||
|
Comprehensive income for the period
|
49,554
|
253
|
-
|
49,807
|
||||||||||||||
|
For the three-month period ended September 30, 2024
|
||||||||||||||||||
|
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||
|
Revenues
|
B |
69,113
|
(2
|
)
|
7,406
|
76,517
|
||||||||||||
|
Operating expenses
|
A |
28,859
|
(2,161
|
)
|
7,406
|
34,104
|
||||||||||||
|
Depreciation and amortization
|
A |
6,867
|
1,765
|
-
|
8,632
|
|||||||||||||
|
Operating profit
|
33,387
|
394
|
-
|
33,781
|
||||||||||||||
|
Finance expenses
|
B,F
|
9,018
|
(871
|
)
|
-
|
8,147
|
||||||||||||
|
Profit for the period
|
24,369
|
1,265
|
-
|
25,634
|
||||||||||||||
|
Other comprehensive income
|
B |
4,480
|
(846
|
)
|
-
|
3,634
|
||||||||||||
|
Comprehensive income for the period
|
28,849
|
419
|
-
|
29,268
|
||||||||||||||
|
For the year ended December 31, 2024
|
||||||||||||||||||
|
US GAAP
|
IFRS adjustments
|
Adjustments to the Group’s accounting policies*
|
IFRS – according to the Group’s accounting policies
|
|||||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
|||||||||||||||
|
Revenues
|
B |
275,102
|
(2,854
|
)
|
27,083
|
299,331
|
||||||||||||
|
Operating expenses
|
A |
121,590
|
(8,648
|
)
|
27,083
|
140,025
|
||||||||||||
|
Depreciation and amortization
|
A |
27,485
|
7,062
|
-
|
34,547
|
|||||||||||||
|
Operating profit
|
126,027
|
(1,268
|
)
|
-
|
124,759
|
|||||||||||||
|
Finance expenses
|
B |
27,325
|
(5,185
|
)
|
-
|
22,140
|
||||||||||||
|
Profit for the year
|
98,702
|
3,917
|
-
|
102,619
|
||||||||||||||
|
Other comprehensive income
|
B |
9,533
|
(1,911
|
)
|
-
|
7,622
|
||||||||||||
|
Comprehensive income for the year
|
108,235
|
2,006
|
-
|
110,241
|
||||||||||||||
|
For the nine-month period ended September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
113,219
|
10,732
|
123,951
|
||||||||||
|
Net cash provided by operating activities
|
129,183
|
-
|
129,183
|
|||||||||||
|
Net cash used for investing activities
|
D |
(2,072
|
)
|
(7,213
|
)
|
(9,285
|
)
|
|||||||
|
Net cash used for financing activities
|
(119,120
|
)
|
-
|
(119,120
|
)
|
|||||||||
|
Net increase in cash and cash equivalents
|
7,991
|
(7,213
|
)
|
778
|
||||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D |
43
|
444
|
487
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D |
4,793
|
(4,793
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D |
199
|
1,066
|
1,265
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D |
12,628
|
(12,628
|
)
|
-
|
|||||||||
|
For the nine-month period ended September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
81,462
|
4,247
|
85,709
|
||||||||||
|
Net cash provided by operating activities
|
101,096
|
-
|
101,096
|
|||||||||||
|
Net cash provided by (used for) investing activities
|
D |
(3,509
|
)
|
10,010
|
6,501
|
|||||||||
|
Net cash used for financing activities
|
(106,268
|
)
|
-
|
(106,268
|
)
|
|||||||||
|
Net increase (decrease) in cash and cash equivalents
|
(8,681
|
)
|
10,010
|
1,329
|
||||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D |
52
|
265
|
317
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D |
28,328
|
(28,328
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D |
85
|
1,561
|
1,646
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D |
19,614
|
(19,614
|
)
|
-
|
|||||||||
|
For the three-month period ended September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
49,964
|
1,131
|
51,095
|
||||||||||
|
Net cash provided by operating activities
|
60,364
|
-
|
60,364
|
|||||||||||
|
Net cash used for investing activities
|
(1,790
|
)
|
(4,251
|
)
|
(6,041
|
)
|
||||||||
|
Net cash used for financing activities
|
(53,334
|
)
|
-
|
(53,334
|
)
|
|||||||||
|
Net increase in cash and cash equivalents
|
D
|
5,240
|
(4,251
|
)
|
989
|
|||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D
|
76
|
200
|
276
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D
|
7,511
|
(7,511
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D
|
199
|
1,066
|
1,265
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D
|
12,628
|
(12,628
|
)
|
-
|
|||||||||
|
For the three-month period ended September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
24,369
|
1,265
|
25,634
|
||||||||||
|
Net cash provided by operating activities
|
30,622
|
-
|
30,622
|
|||||||||||
|
Net cash provided by (used for) investing activities
|
D
|
(1,275
|
)
|
8,792
|
7,517
|
|||||||||
|
Net cash used for financing activities
|
(39,135
|
)
|
-
|
(39,135
|
)
|
|||||||||
|
Net decrease in cash and cash equivalents
|
(9,788
|
)
|
8,792
|
(996
|
)
|
|||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D
|
73
|
2,569
|
2,642
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D
|
29,414
|
(29,414
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D
|
85
|
1,561
|
1,646
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D
|
19,614
|
(19,614
|
)
|
-
|
|||||||||
|
For the year ended December 31, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the year
|
A,B
|
98,702
|
3,917
|
102,619
|
||||||||||
|
Net cash provided by operating activities
|
125,851
|
-
|
125,851
|
|||||||||||
|
Net cash provided by (used for) investing activities
|
D
|
(11,286
|
)
|
23,714
|
12,428
|
|||||||||
|
Net cash used for financing activities
|
(138,109
|
)
|
-
|
(138,109
|
)
|
|||||||||
|
Net increase (decrease) in cash and cash equivalents
|
(23,544
|
)
|
23,714
|
170
|
||||||||||
|
Balance of cash and cash equivalents as of the beginning of the year
|
D
|
52
|
265
|
317
|
||||||||||
|
Restricted cash balance as of the beginning of the year
|
D
|
28,328
|
(28,328
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the year
|
D
|
43
|
444
|
487
|
||||||||||
|
Restricted cash balance as of the end of the year
|
D
|
4,793
|
(4,793
|
)
|
-
|
|||||||||
|
As of September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Cash and cash equivalents
|
D
|
44
|
559
|
603
|
||||||||||
|
Restricted cash
|
D
|
560
|
(559
|
)
|
1
|
|||||||||
|
Property, plant & equipment
|
A,C
|
555,368
|
44,082
|
599,450
|
||||||||||
|
Intangible assets
|
C
|
12,342
|
(12,342
|
)
|
-
|
|||||||||
|
Other assets
|
70,011
|
-
|
70,011
|
|||||||||||
|
Total assets
|
638,325
|
31,740
|
670,065
|
|||||||||||
|
Accounts payable and deferred expenses
|
A
|
11,752
|
(1,957
|
)
|
9,795
|
|||||||||
|
Other liabilities
|
297,177
|
(4,466
|
)
|
292,711
|
||||||||||
|
Total liabilities
|
308,929
|
(6,423
|
)
|
302,506
|
||||||||||
|
Partners’ equity
|
A
|
329,396
|
38,162
|
367,558
|
||||||||||
|
Total liabilities and equity
|
638,325
|
31,739
|
670,064
|
|||||||||||
|
As of September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Cash and cash equivalents
|
D
|
43
|
3,483
|
3,526
|
||||||||||
|
Restricted cash
|
D
|
3,484
|
(3,483
|
)
|
1
|
|||||||||
|
Property, plant & equipment
|
A,C
|
571,409
|
40,294
|
611,703
|
||||||||||
|
Intangible assets
|
C
|
12,741
|
(12,741
|
)
|
-
|
|||||||||
|
Other assets
|
79,969
|
-
|
79,969
|
|||||||||||
|
Total assets
|
667,646
|
27,553
|
695,199
|
|||||||||||
|
Accounts payable and deferred expenses
|
A
|
11,193
|
(1,588
|
)
|
9,605
|
|||||||||
|
Other liabilities
|
359,144
|
(550
|
)
|
358,594
|
||||||||||
|
Total liabilities
|
370,337
|
(2,138
|
)
|
368,199
|
||||||||||
|
Partners’ equity
|
A
|
297,309
|
29,692
|
327,001
|
||||||||||
|
Total liabilities and equity
|
667,646
|
27,554
|
695,200
|
|||||||||||
|
As of December 31, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Cash and cash equivalents
|
D
|
34
|
4,800
|
4,834
|
||||||||||
|
Restricted cash
|
D
|
4,800
|
(4,800
|
)
|
-
|
|||||||||
|
Property, plant & equipment
|
A,C
|
567,685
|
41,156
|
608,841
|
||||||||||
|
Intangible assets
|
C
|
12,641
|
(12,641
|
)
|
-
|
|||||||||
|
Other assets
|
76,181
|
(1
|
)
|
76,180
|
||||||||||
|
Total assets
|
661,341
|
28,514
|
689,855
|
|||||||||||
|
Accounts payable and deferred expenses
|
A
|
11,770
|
(1,375
|
)
|
10,395
|
|||||||||
|
Other liabilities
|
336,376
|
(2,784
|
)
|
333,592
|
||||||||||
|
Total liabilities
|
348,146
|
(4,159
|
)
|
343,987
|
||||||||||
|
Partners’ equity
|
A
|
313,195
|
32,673
|
345,868
|
||||||||||
|
Total liabilities and equity
|
661,341
|
28,514
|
689,855
|
|||||||||||
|
For the nine-month period ended September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Revenues
|
236,403
|
(72
|
)
|
236,331
|
||||||||||
|
Operating expenses
|
A
|
152,299
|
(5,625
|
)
|
146,674
|
|||||||||
|
Depreciation and amortization
|
A
|
14,536
|
136
|
14,672
|
||||||||||
|
Operating profit
|
69,568
|
5,417
|
74,985
|
|||||||||||
|
Finance expenses
|
B
|
15,267
|
(7
|
)
|
15,260
|
|||||||||
|
Profit for the period
|
54,301
|
5,424
|
59,725
|
|||||||||||
|
Other comprehensive loss
|
B
|
(5,750
|
)
|
65
|
(5,685
|
)
|
||||||||
|
Comprehensive income for the period
|
48,551
|
5,489
|
54,040
|
|||||||||||
|
For the nine-month period ended September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Revenues
|
185,861
|
(691
|
)
|
185,170
|
||||||||||
|
Operating expenses
|
A
|
144,579
|
(4,676
|
)
|
139,903
|
|||||||||
|
Depreciation and amortization
|
A
|
13,911
|
2,989
|
16,900
|
||||||||||
|
Operating profit
|
27,371
|
996
|
28,367
|
|||||||||||
|
Finance expenses
|
B
|
17,783
|
(26
|
)
|
17,757
|
|||||||||
|
Profit for the period
|
9,588
|
1,022
|
10,610
|
|||||||||||
|
Other comprehensive income (loss)
|
B
|
(535
|
)
|
665
|
130
|
|||||||||
|
Comprehensive loss for the period
|
9,053
|
1,687
|
10,740
|
|||||||||||
|
For the three-month period ended September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Revenues
|
90,380
|
(93
|
)
|
90,287
|
||||||||||
|
Operating expenses
|
A
|
50,892
|
(1,956
|
)
|
48,936
|
|||||||||
|
Depreciation and amortization
|
A
|
4,856
|
1,062
|
5,918
|
||||||||||
|
Operating profit
|
34,632
|
801
|
35,433
|
|||||||||||
|
Finance expenses
|
B
|
4,851
|
(4
|
)
|
4,847
|
|||||||||
|
Profit for the period
|
29,781
|
805
|
30,586
|
|||||||||||
|
Other comprehensive income
|
B
|
8,109
|
89
|
8,198
|
||||||||||
|
Comprehensive income for the period
|
37,890
|
894
|
38,784
|
|||||||||||
|
For the three-month period ended September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Revenues
|
69,307
|
(308
|
)
|
68,999
|
||||||||||
|
Operating expenses
|
A
|
50,260
|
(1,694
|
)
|
48,566
|
|||||||||
|
Depreciation and amortization
|
A
|
4,810
|
810
|
5,620
|
||||||||||
|
Operating profit
|
14,237
|
576
|
14,813
|
|||||||||||
|
Finance expenses
|
B
|
6,069
|
17
|
6,086
|
||||||||||
|
Profit for the period
|
8,168
|
559
|
8,727
|
|||||||||||
|
Other comprehensive income
|
B
|
4,923
|
325
|
5,248
|
||||||||||
|
Comprehensive income for the period
|
13,091
|
884
|
13,975
|
|||||||||||
|
For the year ended December 31, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Revenues
|
234,641
|
(835
|
)
|
233,806
|
||||||||||
|
Operating expenses
|
A
|
185,058
|
(6,050
|
)
|
179,008
|
|||||||||
|
Depreciation and amortization
|
A
|
18,721
|
1,381
|
20,102
|
||||||||||
|
Operating profit
|
30,862
|
3,834
|
34,696
|
|||||||||||
|
Finance expenses
|
B
|
23,513
|
(18
|
)
|
23,495
|
|||||||||
|
Profit for the year
|
7,349
|
3,852
|
11,201
|
|||||||||||
|
Other comprehensive income
|
B
|
19,340
|
817
|
20,157
|
||||||||||
|
Comprehensive income for the year
|
26,689
|
4,669
|
31,358
|
|||||||||||
|
For the nine-month period ended September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
54,301
|
5,424
|
59,725
|
||||||||||
|
Net cash provided by operating activities
|
70,545
|
-
|
70,545
|
|||||||||||
|
Net cash provided by (used for) investing activities
|
D
|
(1,927
|
)
|
2,422
|
495
|
|||||||||
|
Net cash used for financing activities
|
(75,271
|
)
|
-
|
(75,271
|
)
|
|||||||||
|
Net decrease in cash and cash equivalents
|
(6,653
|
)
|
2,422
|
(4,231
|
)
|
|||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D
|
34
|
4,800
|
4,834
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D
|
29,040
|
(29,040
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D
|
44
|
559
|
603
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D
|
22,377
|
(22,377
|
)
|
-
|
|||||||||
|
For the nine-month period ended September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
9,588
|
1,022
|
10,610
|
||||||||||
|
Net cash provided by operating activities
|
12,592
|
-
|
12,592
|
|||||||||||
|
Net cash used for investing activities
|
D
|
(7,887
|
)
|
300
|
(7,587
|
)
|
||||||||
|
Net cash used for financing activities
|
(5,861
|
)
|
-
|
(5,861
|
)
|
|||||||||
|
Net decrease in cash and cash equivalents
|
(1,156
|
)
|
300
|
(856
|
)
|
|||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D
|
41
|
4,341
|
4,382
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D
|
28,917
|
(28,917
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D
|
43
|
3,483
|
3,526
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D
|
27,759
|
(27,759
|
)
|
-
|
|||||||||
|
For the three-month period ended September 30, 2025
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
29,781
|
805
|
30,586
|
||||||||||
|
Net cash provided by operating activities
|
37,449
|
-
|
37,449
|
|||||||||||
|
Net cash used for investing activities
|
D
|
(871
|
)
|
799
|
(72
|
)
|
||||||||
|
Net cash used for financing activities
|
(41,264
|
)
|
-
|
(41,264
|
)
|
|||||||||
|
Net decrease in cash and cash equivalents
|
(4,686
|
)
|
799
|
(3,887
|
)
|
|||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D
|
44
|
4,446
|
4,490
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D
|
27,063
|
(27,063
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D
|
44
|
559
|
603
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D
|
22,377
|
(22,377
|
)
|
-
|
|||||||||
|
For the three-month period ended September 30, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the period
|
A,B
|
8,168
|
559
|
8,727
|
||||||||||
|
Net cash provided by operating activities
|
10,039
|
-
|
10,039
|
|||||||||||
|
Net cash provided by (used for) investing activities
|
D
|
(405
|
)
|
1,102
|
697
|
|||||||||
|
Net cash used for financing activities
|
(8,149
|
)
|
-
|
(8,149
|
)
|
|||||||||
|
Net increase in cash and cash equivalents
|
1,485
|
1,102
|
2,587
|
|||||||||||
|
Balance of cash and cash equivalents as of the beginning of the period
|
D
|
44
|
895
|
939
|
||||||||||
|
Restricted cash balance as of the beginning of the period
|
D
|
26,273
|
(26,273
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the period
|
D
|
43
|
3,483
|
3,526
|
||||||||||
|
Restricted cash balance as of the end of the period
|
D
|
27,759
|
(27,759
|
)
|
-
|
|||||||||
|
For the year ended December 31, 2024
|
||||||||||||||
|
US GAAP
|
Adjustments
|
IFRS
|
||||||||||||
|
In USD thousand
|
In USD thousand
|
In USD thousand
|
||||||||||||
|
Profit for the year
|
A,B
|
7,349
|
3,852
|
11,201
|
||||||||||
|
Net cash provided by operating activities
|
22,178
|
-
|
22,178
|
|||||||||||
|
Net cash used for investing activities
|
D
|
(8,882
|
)
|
336
|
(8,546
|
)
|
||||||||
|
Net cash used for financing activities
|
(13,180
|
)
|
-
|
(13,180
|
)
|
|||||||||
|
Net increase in cash and cash equivalents
|
116
|
336
|
452
|
|||||||||||
|
Balance of cash and cash equivalents as of the beginning of the year
|
D
|
41
|
4,341
|
4,382
|
||||||||||
|
Restricted cash balance as of the beginning of the year
|
D
|
28,917
|
(28,917
|
)
|
-
|
|||||||||
|
Balance of cash and cash equivalents as of the end of the year
|
D
|
34
|
4,800
|
4,834
|
||||||||||
|
Restricted cash balance as of the end of the year
|
D
|
29,040
|
(29,040
|
)
|
-
|
|||||||||
| A. |
Maintenance costs under the Long Term Maintenance Plan (hereinafter – the “LTPC Agreement”): under IFRS, variable payments which were paid in accordance with the milestones as set in the LTPC
Agreement are capitalized to the cost of property, plant and equipment and amortized over the period from the date on which maintenance work was carried out until the date on which maintenance work is due to take place again. Under US GAAP,
the said payments are recognized on payment date within current expenses in the statement of income.
|
| B. |
Hedge effectiveness of swaps: in accordance with the IFRS – the associates recognize adjustments relating to the ineffective portion of their cash flow hedge under profit and loss. Under US GAAP, there is no part which is not effective,
and the hedging results are recognized in full in other comprehensive income.
|
| C. |
Intangible assets: Under IFRS, certain intangible assets are defined as property, plant and equipment.
|
| D. |
Restricted cash: There is a difference between the presentation and classification of restricted cash in the cash flow statements and in the statements of financial position.
|
| E. |
Right-of-use assets: In IFRS, certain contracts are classified as leases. Under US GAAP, these contracts do not meet the definition of lease contracts, and are recorded as operating expenses.
|
| F. |
Changes in financing and refinancing agreements: In cases where the Group has made a modification of terms in existing loans and the change is immaterial, in accordance with IFRS 9, the carrying value of the loans has been adjusted to
reflect the present value of the updated contractual cash flows, discounted according to the original effective interest rate. The difference resulting from this adjustment was immediately recognized in the income statement. Under US GAAP,
there was no effect on profit or loss date on which the terms and conditions were changed.
|